The results of left ventricular volume studies using biplane angiocardiography are described in 20 patients with mitral regurgitation and in 27 patients with aortic regurgitation. In both lesions, a regurgitantfraction of over 6o per cent was likely to be associated with severe symptoms and most patients in this group required operation. End-diastolic volumes were higher in patients with aortic regurgitation and were tolerated withfewer symptoms than in the group with mitral regurgitation. Most (19/2I) of the patients with low ejection fractions ( < o6o) had either rheumatic valvular lesions or had had potassium citrate as a cardioplegic drug at previous heart operations. The While in chronic regurgitant lesions the augmented demand for ejected volume is primarily compensated for by increased preloading of the ventricle, i.e. a larger enddiastolic volume (Hugenholtz and Wagner, I970), in acutely induced regurgitant lesions it has been observed that suddenly reduced
Determination of left ventricular volumes during systole and diastole has made it possible to measure the amount of regurgitant flow in lesions with valvular insufficiency (Sandler et al., I963) . The possibility that this assessment may aid in the management of patients with aortic and mitral regurgitation by separating out those who have myocardial dysfunction in addition to their valve lesion led us to relate the volume parameters to the clinical findings and course in a group of 47 children and young adults with these lesions.
While in chronic regurgitant lesions the augmented demand for ejected volume is primarily compensated for by increased preloading of the ventricle, i.e. a larger enddiastolic volume (Hugenholtz and Wagner, I970) , in acutely induced regurgitant lesions it has been observed that suddenly reduced afterload may lead to a higher than normal ejection fraction (Urschel et al., I968) , without the need for cardiac dilatation. Hence, this study was further designed to determine if a 'normal' ejection fraction might be associated with clinical symptoms indicative of congestive heart failure.
Subjects and methods
There were 20 female and 27 male patients: 27 patients had aortic regurgitation, with a mean age of I7-8 years (range 5-44 years), and 20 patients had mitral regurgitation, with a mean age of I5.4 years (range 4-43 years); 23 patients had rheumatic lesions, 24 patients had congenital lesions.
Ofthe i8 patients with congenital aortic regurgitation, there was associated significant aortic stenosis in 2, and there had been previous operations for aortic stenosis in 9.
All the data were obtained during diagnostic cardiac catheterization using methods previously described from this institution (Hugenholtz and Wagner, I970) . Biplane left ventricular angiocardiograms were taken at 6 or I2 frames per second. Methylglucamine diatrizoate was injected as the contrast medium in a dose ofapproximately i ml./kg. The first few cardiac cycles after the injection of contrast were analysed in order to avoid alterations in contraction secondary to the haemodynamic effects of the contrast medium. without symptoms, but 3 of the 7 were symptomatic enough to require corrective operations.
A comparison was made between the degree of left atrial enlargement and the regurgitant fraction in the mitral regurgitant group. Though most of the patients with a regurgitant fraction over 6oper cent had appreciable left atrial dilatation, while none of the patients with a regurgitant fraction under 30 per cent did so, there was not a good predictive value to the degree of regurgitation from the size of the left atrium.
In the aortic regurgitant group, the regurgitant fraction was closely related to severity of symptoms (Fig. I) Three others with an ejection fraction below os58 had moderate symptoms and were in functional Class II. All 6 patients with a fraction below o 5o had rheumatic mitral regurgitation.
In the group with aortic regurgitation, there was no clear relation between the ejection fraction and the severity of the symptomatology. The ejection fraction in the severely symptomatic cases ranged from o053 to o076. Ofthe patients with an ejection fraction ofo 55 or less, 4 had rheumatic aortic valve disease and 3 had congenital aortic valve disease. Of the latter, 2 had been given potassium citrate as a cardioplegic drug during previous operation for aortic stenosis. All are free from symptoms at present. Two other patients in this group, also with potassium citrate arrests, had ejection fractions of os58 and o082. It seems, therefore, that use of this drug, now out of com- had mitral regurgitation due to ruptured chordae tendineae, and several of these had high or normal ejection fractions in spite of having symptoms. This may be related to the sudden onset of the lesion with a sudden rise in pulmonary venous pressure due to regurgitation into a small non-compliant atrium resulting in severe symptoms before any significant deterioration of myocardial function has occurred.
There is general agreement between these results and those reported here in that, in pure aortic or mitral regurgitation, a regurgitant fraction of over 6o per cent indicates a severe lesion. Almost all of the patients reported in these series who required an operation had regurgitant fractions in this range.
It appears that symptoms in mitral and aortic regurgitation may vary considerably according to the aetiology and speed of onset of the lesion. If, for example, there has been perforation of an aortic cusp or rupture of mitral chordae tendineae, acute regurgitation occurs into a relatively small, non-compliant chamber with a resultant rapid rise in pulmonary venous pressure and early onset of pulmonary oedema. Thus, the relation of left atrial size to symptoms in the mitral regurgitation group will reflect this variation. A high regurgitant fraction is only one ofthe elements contributing to left atrial size; duration of the regurgitation and wall compliance are other important features. As a consequence, size of the atrium cannot be taken as a reliable indicator of the severity of mitral regurgitation.
With long-standing congenital or rheumatic valvular insufficiency, the left ventricle and left atrium may dilate slowly without any conspicuous rise in pulmonary venous pressure. A progressively lower cardiac output and congestive heart failure without acute pulmonary oedema may then occur when the myocardium begins to fail. This stage may be detected by finding a reduced ejection fraction in the face of a normal or increased enddiastolic volume and/or a normal or decreased peripheral resistance. The mechanism responsible for producing this reduced contractility of the myocardium is uncertain. In the rheumatic group Three of the patients studied here died in the post-operative period. Two of these died from infection and one, who had an ejection fraction of o039, died on the first post-operative day after atelectasis. One other patient with mitral regurgitation had an even lower ejection fraction of o034, yet survived operation and is doing well 3 years after valve replacement. Therefore, a low ejection fraction should not be an absolute contraindication to valve operation, but the presence of a low ejection fraction without a large regurgitant fraction suggests that the valve lesion is relatively mild, and raises the suspicion of a more significant myocardial disorder. It is felt that long-term follow-up will be necessary to assess the prognostic significance of a depressed ejection fraction. Urschel et al. (I968) have shown that the acute production of mitral or aortic insufficiency causes an increase in ejection fraction due to the sudden decrease in the impedance to ejection, the afterload. Thus, a 'normal' ejection fraction in a patient with a regurgitant lesion and a healthy myocardium may well be above 6o per cent, which we selected as a lower normal limit for the age-group studied. 
